AzTrials
AzTrials

CaffeineNCT04642131

Effect of Caffeine Supplementation and Personalized Insoles on Females

A study testing Caffeine supplementation and Personalized insoles in people with Caffeine and Fatigue, run by Universidad de Zaragoza at 1 site in Spain.

Suspended

Paused. Enrolment is on hold for now and may resume.

Official record
Search all trials

Trial summary

Several studies have shown the positive effect that caffeine has on athletic performance related variables. Nonetheless, most studies have been developed in males and have not studied the possible effects on biomechanics and related injuries. Read more about this study

Who is it for?
Ages 18 years and older, women onlyHealthy volunteers can take part
Conditions the study is for
Caffeine, Fatigue, Injuries
What is being tested?
Caffeine supplementation and Personalized insoles
Type of treatment
Medical device
Could I receive a placebo?
Yes, some participants may receive a placebo
How many people
16 participants
Where
1 siteSpain
Study dates
9 Dec 2020to 31 Dec 2025
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • Women only
  • Healthy volunteers accepted
  • Adult, Older adult

Who may be able to join

  • Females
  • Soccer players who have been competing for at least 3 years

Who cannot join

  • Participants with major injuries in the lower limbs within the 12 months before testing.
  • Participants consuming ephedrine or related medicines

Trial locations and contacts

1 site in 1 country.

Spain1 site
  • Universidad de Zaragoza

    Zaragoza, 50012

Other trials in Spain

About this study

Official title: The Effect of Fatigue, Caffeine Supplementation and Personalized Insoles on Biomechanics and Athletic Performance in Female Adult Soccer Players.

Several studies have shown the positive effect that caffeine has on athletic performance related variables. Nonetheless, most studies have been developed in males and have not studied the possible effects on biomechanics and related injuries. Moreover, the inclusion of personalized insoles could also affect biomechanical patterns and thus injury incidence that has shown to be higher when athletes are fatigued. Therefore, the aim of the present randomized controlled trial is to evaluate the effect of fatigue, caffeine supplementation and personalized insoles on biomechanics and athletic performance in female adult soccer players.

Being tested
Caffeine supplementation, Personalized insoles, Control condition
Keywords
women, insoles, kinematics, kinetics, performance, athletics, team sport
Medical subject headings
Fatigue, Wounds and Injuries, Disorder of Sex Development, 46,XY

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Caffeine supplementationDietary supplement

    Participants will wear standard insoles and ingest caffeine in liquid form (3mg/kg) with carbohydrates.

  • Personalized insolesDevice

    Participants will wear personalized insoles and ingest a drink of carbohydrates without caffeine

  • Control conditionOther

    Participants will wear standard insoles and ingest a drink of carbohydrates without caffeine

Study groups in NCT04642131
Study groupRoleWhat they receive
Personalized insolesExperimentalPersonalized insoles without supplementation
Receives: Device: Personalized insoles
Caffeine supplementationExperimentalStandard insoles with caffeine supplementation (3mg/kg)
Receives: Dietary Supplement: Caffeine supplementation
Control conditionPlacebo comparatorStandard insoles without supplementation
Receives: Other: Control condition

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Agility after fatigue and caffeine supplementation

    Assessment of agility in seconds before and after a fatigue protocol is applied. Data will be collected with photoelectric cells.

    Measured: One day

  2. Jump height after fatigue and caffeine supplementation

    Assessment of jump height in centimetres before and after a fatigue protocol is applied. Data will be collected with force plates.

    Measured: One day

  3. Repeated sprint ability after fatigue and caffeine supplementation

    Assessment of repeated sprints ability in seconds before and after a fatigue protocol is applied. Data will be collected with photoelectric cells.

    Measured: One day

  4. Agility after fatigue and personalized insoles

    Assessment of agility in seconds before and after a fatigue protocol is applied. Data will be collected with photoelectric cells.

    Measured: One day

  5. Jump height after fatigue and personalized insoles

    Assessment of jump height in centimetres before and after a fatigue protocol is applied. Data will be collected with force plates.

    Measured: One day

  6. Repeated sprint ability after fatigue and personalized insoles

    Assessment of repeated sprints ability in seconds before and after a fatigue protocol is applied. Data will be collected with photoelectric cells.

    Measured: One day

  7. Agility after fatigue and placebo

    Assessment of agility in seconds before and after a fatigue protocol is applied. Data will be collected with photoelectric cells.

    Measured: One day

  8. Jump height after fatigue and placebo

    Assessment of jump height in centimetres before and after a fatigue protocol is applied. Data will be collected with force plates.

    Measured: One day

  9. Repeated sprint ability after fatigue and placebo

    Assessment of repeated sprints ability in seconds before and after a fatigue protocol is applied. Data will be collected with photoelectric cells.

    Measured: One day

  10. Hip range of motion after fatigue and caffeine supplementation

    Assessment of hip range of motion in degrees assessed with VICON before and after a fatigue protocol is applied. Data will be collected with the VICON motion capture system.

    Measured: During the intervention

  11. Knee range of motion after fatigue and caffeine supplementation

    Assessment of knee range of motion in degrees assessed with VICON before and after a fatigue protocol is applied. Data will be collected with the VICON motion capture system.

    Measured: During the intervention

  12. Ankle range of motion after fatigue and caffeine supplementation

    Assessment of ankle range of motion in degrees assessed with VICON before and after a fatigue protocol is applied. Data will be collected with the VICON motion capture system.

    Measured: During the intervention

  13. Hip flexion moment after fatigue and caffeine supplementation

    Assessment of hip flexion moment in Nm·kg assessed with VICON before and after a fatigue protocol is applied. Data will be collected with the VICON motion capture system.

    Measured: During the intervention

  14. Knee flexion moment after fatigue and caffeine supplementation

    Assessment of knee flexion moment in Nm·kg assessed with VICON before and after a fatigue protocol is applied. Data will be collected with the VICON motion capture system.

    Measured: During the intervention

  15. Ankle flexion moment after fatigue and caffeine supplementation

    Assessment of ankle flexion moment in Nm·kg assessed with VICON before and after a fatigue protocol is applied. Data will be collected with the VICON motion capture system.

    Measured: During the intervention

  16. Hip range of motion after fatigue and personalized insoles

    Assessment of hip range of motion in degrees assessed with VICON before and after a fatigue protocol is applied. Data will be collected with the VICON motion capture system.

    Measured: During the intervention

  17. Knee range of motion after fatigue and personalized insoles

    Assessment of knee range of motion in degrees assessed with VICON before and after a fatigue protocol is applied. Data will be collected with the VICON motion capture system.

    Measured: During the intervention

  18. Ankle range of motion after fatigue and personalized insoles

    Assessment of ankle range of motion in degrees assessed with VICON before and after a fatigue protocol is applied. Data will be collected with the VICON motion capture system.

    Measured: During the intervention

  19. Hip flexion moment after fatigue and personalized insoles

    Assessment of hip flexion moment in Nm·kg assessed with VICON before and after a fatigue protocol is applied. Data will be collected with the VICON motion capture system.

    Measured: During the intervention

  20. Knee flexion moment after fatigue and personalized insoles

    Assessment of knee flexion moment in Nm·kg assessed with VICON before and after a fatigue protocol is applied. Data will be collected with the VICON motion capture system.

    Measured: During the intervention

  21. Ankle flexion moment after fatigue and personalized insoles

    Assessment of ankle flexion moment in Nm·kg assessed with VICON before and after a fatigue protocol is applied. Data will be collected with the VICON motion capture system.

    Measured: During the intervention

  22. Hip range of motion after fatigue and placebo

    Assessment of hip range of motion in degrees assessed with VICON before and after a fatigue protocol is applied. Data will be collected with the VICON motion capture system.

    Measured: During the intervention

  23. Knee range of motion after fatigue and placebo

    Assessment of knee range of motion in degrees assessed with VICON before and after a fatigue protocol is applied. Data will be collected with the VICON motion capture system.

    Measured: During the intervention

  24. Ankle range of motion after fatigue and placebo

    Assessment of ankle range of motion in degrees assessed with VICON before and after a fatigue protocol is applied. Data will be collected with the VICON motion capture system.

    Measured: During the intervention

  25. Hip flexion moment after fatigue and placebo

    Assessment of hip flexion moment in Nm·kg assessed with VICON before and after a fatigue protocol is applied. Data will be collected with the VICON motion capture system.

    Measured: During the intervention

  26. Knee flexion moment after fatigue and placebo

    Assessment of knee flexion moment in Nm·kg assessed with VICON before and after a fatigue protocol is applied. Data will be collected with the VICON motion capture system.

    Measured: During the intervention

  27. Ankle flexion moment after fatigue and placebo

    Assessment of ankle flexion moment in Nm·kg assessed with VICON before and after a fatigue protocol is applied. Data will be collected with the VICON motion capture system.

    Measured: During the intervention

Secondary outcomes (4)
  1. Injury incidence

    Association between the primary outcomes and injury incidence registered through the International Federation of Association Football questionnaire (F-MARC)

    Measured: Six months

  2. Sleep disturbances after caffeine ingestion

    Rate of patients with sleep problems assessed with the Athens sleep questionnaire

    Measured: Immediately after the intervention

  3. Sleep disturbances after personalized insoles

    Rate of patients with sleep problems assessed with the Athens sleep questionnaire

    Measured: Immediately after the intervention

  4. Sleep disturbances after placebo

    Rate of patients with sleep problems assessed with the Athens sleep questionnaire

    Measured: Immediately after the intervention

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted24 Nov 2020
  2. Study start9 Dec 2020
  3. Primary completion1 Jul 2024 (estimated)
  4. Study completion31 Dec 2025 (estimated)

Why it stopped: Were unable to recruit enough participants and the agreement with the laboratory providing the measurements stoped.

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Diagnosis
Allocation
Randomised
Intervention model
Crossover
Model description
Participants will be given a bottle with either caffeine and carbohydrates or just carbohydrates, and personalized insoles or standard insoles. All participants will complete athletic and biomechanics tests before and after completing a 43 minute fatigue protocol.
Masking
Double blind
Who is masked
Participant, Investigator
Enrolment
16 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT04642131
Sponsor's protocol ID
UZCUD2020-BIO-02
Status last verified
May 2024
First submitted
6 Nov 2020
Last updated
8 May 2024
Results posted
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Undecided

Questions about this trial

What is this clinical trial studying?

A study testing Caffeine supplementation and Personalized insoles in people with Caffeine and Fatigue, run by Universidad de Zaragoza at 1 site in Spain.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 2 inclusion and 2 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: paused, as of the sponsor's last update on 8 May 2024. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Spain. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. Some participants in this study may receive a placebo. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Agility after fatigue and caffeine supplementation (time frame: One day). The study lists 27 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 8 May 2024.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in